Clinical Trial Update: VTP-1000 in Adults With Celiac Disease [EARLY_Phase 1]

View source ↗

Summary

Barinthus Biotherapeutics is conducting an early Phase 1 trial of VTP-1000 in adults with celiac disease, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• VTP-1000

Snippet

Sponsor: Barinthus Biotherapeutics | Conditions: Celiac Disease | EARLY_Phase 1 | Status: RECRUITING